| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a0d225cdb54911563f332b5f7780017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c42302ace66a35be3c8138a8364367bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada5df21bfad0b29ffa4aa97e80baac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69eb6468b54528fa7d4c741b1fbf027c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcb619e29d762fae742ca479229f7922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9797d6424ebfea8151261c8dcbf22bc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3e91b41d7bfae00093a458dee95eb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7dceed53c635622a0ada7f02701028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc36c5def1c8ad9d940ae1fcd950e7b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152716e9c1d420d6297a3b2f63e06e8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_626411a077179bee99d6802c6e5987dd |
| publicationDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004081046-A2 |
| titleOfInvention |
Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| abstract |
The present invention relates to novel therapies and treatments of atherosclerotic diseases. Accordingly there is provided, methods of treating or preventing atherosclerosis by passive vaccination through administration to a patient of a human antibody that is capable of binding to the specific fragments of ApoCIII. Specific human monoclonal antibodies and their use in therapy of atherosclerosis is provided. There is further provided the use of the antibodies of the present invention in medicine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018007999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9783600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106810606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019525772-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021119482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109689685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010127642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014131008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020070678-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012315276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11242381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248042-B2 |
| priorityDate |
2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |